Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019

Mathaiyan, Jayanthi; Ganesan, Prasanth; Kadhiravan, Tamilarasu; Anandabaskar, Nishanthi

doi:10.4103/jpp.jpp_173_20

Meeting Reports (Ethics)Journal of Pharmacology and PharmacotherapeuticsVol. 11 | Issue 4 | 2021 | pp. 148–150Open access

Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019

¹^*,
²,
³,
⁴

¹ Department of Pharmacology, JIPMER, Puducherry, India.
² Department of Medical Oncology, JIPMER, Puducherry, India.
³ Department of Medicine, JIPMER, Puducherry, India.
⁴ Department of Pharmacology, Sri Manakula Vinayagar Medical College Hospital, Puducherry, India.

Correspondence: Jayanthi Mathaiyan
Department of Pharmacology, JIPMER, Puducherry, India.
Email: drjayanthi2008@gmail.com

Published:: May 14, 2021
Received:: Dec 24, 2020
Accepted:: Dec 29, 2020
DOI:: 10.4103/jpp.jpp_173_20

How to cite

Mathaiyan, J., Ganesan, P., Kadhiravan, T., & Anandabaskar, N. (2021). Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 148–150. https://doi.org/10.4103/jpp.jpp_173_20

Abstract

No abstract available.

Subject

Article metadata

Title	Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019
Authors	Jayanthi Mathaiyan; Prasanth Ganesan; Tamilarasu Kadhiravan; Nishanthi Anandabaskar
Affiliations	Department of Pharmacology, JIPMER, Puducherry, India.; Department of Medical Oncology, JIPMER, Puducherry, India.; Department of Medicine, JIPMER, Puducherry, India.; Department of Pharmacology, Sri Manakula Vinayagar Medical College Hospital, Puducherry, India.
Corresponding author	drjayanthi2008@gmail.com
Journal	Journal of Pharmacology and Pharmacotherapeutics
Volume / Issue	Vol. 11, Issue 4 (2021)